A new hypothesis linking oxytocin to menstrual migraine

CONCLUSION: Trigeminal OTR may thus be a novel target for the development of MRM therapeutics.PMID:34125955 | DOI:10.1111/head.14152

Source: Headache - June 14, 2021 Category: Neurology Authors: Vimala N Bharadwaj Frank Porreca Robert P Cowan Shashidhar Kori Stephen D Silberstein David C Yeomans Source Type: research